实用器官移植电子杂志 ›› 2013, Vol. 1 ›› Issue (4): 229-231.

• 论著 • 上一篇    下一篇

肾移植术后重症肺炎撤除免疫抑制剂治疗的安全性评估

姜伟,刘彦斌,裴向克,高建,杨其顺
  

  1. 解放军北戴河二八一医院北京军区肾脏移植中心泌尿外科,河北 秦皇岛 066100
  • 出版日期:2013-07-20 发布日期:2021-04-27

Safety assessment of immunosuppressive therapy discontinuation in severe pneumonia patients after kidney transplantation

JIANG Wei,LIU Yan-bin,PEI Xiang-ke,GAO Jian,YANG Qi-shun.
  

  1. The People's Liberation Army Beidaihe 281Hospitals Beijing Military Area Command Kidney Transplant Center Urology,Qinhuangdao 066100,Hebei,China
  • Online:2013-07-20 Published:2021-04-27

摘要:

目的 探讨肾移植术后重症肺炎的诊治经验。方法 回顾性分析 16 例肾移植术后重症肺炎患者的临床资料。16 例患者均撤除了全部基础免疫抑制剂,经验性使用抗感染药物,并进行病原学检查,根据检查结果调整抗感染方案 ;同时静脉给予小剂量甲泼尼龙、营养支持治疗 ;如出现呼吸困难、血气分 析显示低氧血症,则立即给予无创通气或气管插管治疗,评价其安全性。结果 16 例患者无一例出现急性排斥反应 ;重症肺炎常发生在肾移植术后 3~4 个月,但移植一年以上的重症肺炎也有一定比例 18.75% 3/16);发热和胸闷是最常见首发症状,仅有 18.75%3/16)的患者具有明显的咳嗽、咳痰症状;血培养、痰、咽拭子培养病原体检出率较低(43.75%)。13 例重症肺炎患者治疗有效,3 例死亡,死亡病例均为移植 1 年以上,有移植肾功能不全的诊断。结论 肾移植术后重症肺炎,病情严重、死亡率高。早期诊断、早期经 验性抗感染治疗,撤除全部基础免疫抑制剂,静脉使用激素,进行无创通气及加强全身支持治疗,是肾移植术后重症肺炎治疗成功的关键。治疗期间全部撤除免疫抑制剂药物对患者安全有益,短期内对移植肾无害。

关键词:

Abstract:

Objective To explore the experience of diagnosis and treatment of severe pneumonia afterkidney transplantation. Methods Clinical data of 16 cases with severe pneumonia after kidney transplantation wereretrospectively analyzed. All 16 patients were discontinued based immunosuppressant,antibiotics was empiricallyused and etiology was checked. Antibiotics were adjusted according to the test results. At the same time small doseof prednisolone and nutrition support were prescribed venously. Once there was difficulty in breathing and bloodgas analysis suggested hypoxemia,an immediate noninvasive ventilation or endotracheal intubation treatment wasinitiated and its safety was evaluated. Results 16 patients did not show acute rejection. Severe pneumonia oftenoccurred in 3 to 4 months after kidney transplantation. The proportion of patients with severe pneumonia happenedafter 1 year was 18.75%(3/16). Fever and dyspnea was the most common onset symptom ;there were 18.75%(3/16)of patients with obvious cough and sputum ;pathogen detection rate of blood,phlegm and pharynx swab was
low(43.75%). 13 cases of severe pneumonia patients recovered while 3 died,all who got transplantation over 1 yearand had a diagnosis of transplant renal insufficiency. Conclusions Patients with severe pneumonia after kidneytransplantation is severe with high mortality. Early diagnosis,early empirical anti-infection treatment,discontinuationof all based immunosuppressants,intravenous corticosteroids,noninvasive ventilation and strengthen the body supporttherapy are key points of successful treatment of severe pneumonia after kidney transplantation. Discontinuation of allimmunosuppressant during the treatment is good for patients' safety,and is harmfulless to the transplanted kidney inthe short term.

Key words:

Kidney transplant, Severe pneumonia, Discontinuation, Immunosuppressant, Safety